BioCentury | Mar 12, 2001
Clinical News

Infanrix DTaP-HepB-IPV regulatory update

...Related Biological Products Advisory Committee recommended 6-5, with one abstension, against approval of GSK's Infanrix DTaP-HepB-IPV...
...the meeting were concerned with adequate efficacy data, increased rates of fever and data when DTaP-HepB-IPV...
...vaccine. GSK's Infanrix DTaP vaccine already is marketed in the U.S. and Europe. Infanrix HeXa DTaP-HepB-IPV-Hib...
BioCentury | Mar 8, 2001
Company News

FDA panel rejects GlaxoSmithKline vaccine

...Related Biological Products Advisory Committee recommended 6-to-5, with one abstension, against approval of GSK's Infanrix DTaP-HepB-IPV...
...vaccine. GSK's Infanrix DTaP vaccine already is marketed in the U.S. and Europe. Infanrix HeXa DTaP-HepB-IPV-Hib...
Items per page:
1 - 2 of 2